Serum Indoleamine 2,3-Dioxygenase Activity Is Associated With Reduced Immunogenicity Following Vaccination With MVA85A

BMC Infectious Diseases - United Kingdom
doi 10.1186/s12879-014-0660-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Indole Peroxygenase Activity of Indoleamine 2,3-Dioxygenase

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Indoleamine 2,3-Dioxygenase 1 (IDO1)

Science-Business eXchange
2012English

Decreased Indoleamine 2,3-Dioxygenase Activity and IL-10/IL-17A Ratio in Patients With COPD

Thorax
PulmonaryRespiratory Medicine
2012English

Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth With Ethyl Pyruvate

Cancer Research
Cancer ResearchOncology
2010English

Indoleamine-2,3-Dioxygenase and Interleukin-6 Associated With Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer

Oncotarget
Oncology
2017English

Inhibition of Experimental Asthma by Indoleamine 2,3-Dioxygenase

Journal of Clinical Investigation
Medicine
2004English

Induction of Pulmonary Indoleamine 2,3-Dioxygenase by Interferon.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1981English

Advances in Indoleamine 2,3-Dioxygenase 1 Medicinal Chemistry

MedChemComm
Organic ChemistryMolecular MedicinePharmacologyBiochemistryPharmaceutical ScienceDrug Discovery
2017English

Up‐regulation of Indoleamine 2,3‐dioxygenase 1 (IDO1) Expression and Catalytic Activity Is Associated With Immunosuppression and Poor Prognosis in Penile Squamous Cell Carcinoma Patients

Cancer Communications
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy